<DOC>
	<DOCNO>NCT00856193</DOCNO>
	<brief_summary>This study intend assess well inhaled NVA237 open airways patient mild , moderate severe COPD 24 hour period 14 day treatment period .</brief_summary>
	<brief_title>A Study Investigate Bronchodilatory Effect NVA237 Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Male female age great 40 year COPD Current exsmokers Cardiac ( heart ) disorder , history asthma , require oxygen therapy . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>COPD</keyword>
	<keyword>Bronchodilator</keyword>
</DOC>